Innate immune responses in RNA viral infection.
- Published in:
- Frontiers of Medicine, 2021, v. 15, n. 3, p. 333, doi. 10.1007/s11684-020-0776-7
- By:
- Publication type:
- Article
Works matching IS 20950217 AND DT 2021 AND VI 15 AND IP 3
Results: 12
1
2
Mechanism of insulin resistance in obesity: a role of ATP.
- Published in:
- Frontiers of Medicine, 2021, v. 15, n. 3, p. 372, doi. 10.1007/s11684-021-0862-5
- By:
- Publication type:
- Article
3
Low-carbohydrate diets lead to greater weight loss and better glucose homeostasis than exercise: a randomized clinical trial.
- Published in:
- Frontiers of Medicine, 2021, v. 15, n. 3, p. 460, doi. 10.1007/s11684-021-0861-6
- By:
- Publication type:
- Article
4
Challenges and opportunities in improving left ventricular remodelling and clinical outcome following surgical and trans-catheter aortic valve replacement.
- Published in:
- Frontiers of Medicine, 2021, v. 15, n. 3, p. 416, doi. 10.1007/s11684-021-0852-7
- By:
- Publication type:
- Article
5
Resveratrol promotes the survival and neuronal differentiation of hypoxia-conditioned neuronal progenitor cells in rats with cerebral ischemia.
- Published in:
- Frontiers of Medicine, 2021, v. 15, n. 3, p. 472, doi. 10.1007/s11684-021-0832-y
- By:
- Publication type:
- Article
6
Repurposing clinical drugs is a promising strategy to discover drugs against Zika virus infection.
- Published in:
- Frontiers of Medicine, 2021, v. 15, n. 3, p. 404, doi. 10.1007/s11684-021-0834-9
- By:
- Publication type:
- Article
7
Identification of COL3A1 variants associated with sporadic thoracic aortic dissection: a case-control study.
- Published in:
- Frontiers of Medicine, 2021, v. 15, n. 3, p. 438, doi. 10.1007/s11684-020-0826-1
- By:
- Publication type:
- Article
8
Tocilizumab in patients with moderate or severe COVID-19: a randomized, controlled, open-label, multicenter trial.
- Published in:
- Frontiers of Medicine, 2021, v. 15, n. 3, p. 486, doi. 10.1007/s11684-020-0824-3
- By:
- Publication type:
- Article
9
Emerging molecular subtypes and therapeutic targets in B-cell precursor acute lymphoblastic leukemia.
- Published in:
- Frontiers of Medicine, 2021, v. 15, n. 3, p. 347, doi. 10.1007/s11684-020-0821-6
- By:
- Publication type:
- Article
10
Proteins moonlighting in tumor metabolism and epigenetics.
- Published in:
- Frontiers of Medicine, 2021, v. 15, n. 3, p. 383, doi. 10.1007/s11684-020-0818-1
- By:
- Publication type:
- Article
11
Prohibitin regulates mTOR pathway via interaction with FKBP8.
- Published in:
- Frontiers of Medicine, 2021, v. 15, n. 3, p. 448, doi. 10.1007/s11684-020-0805-6
- By:
- Publication type:
- Article
12
The "Traditional Chinese medicine regulating liver regeneration" treatment plan for reducing mortality of patients with hepatitis B-related liver failure based on real-world clinical data.
- Published in:
- Frontiers of Medicine, 2021, v. 15, n. 3, p. 495, doi. 10.1007/s11684-020-0790-9
- By:
- Publication type:
- Article